31 Recruiting Lymphoma, Non-Hodgkin Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Lymphoma, Non-Hodgkin
Related Conditions
Top Recruiting Lymphoma, Non-Hodgkin Studies
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
📍 Colorado Blood Cancer Institute — Denver, Colorado
View Study & Checklist ➔A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)
📍 Local Institution - 111 — Santa Monica, California
View Study & Checklist ➔A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
📍 City of Hope — Duarte, California
View Study & Checklist ➔Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
📍 Washington University — St Louis, Missouri
View Study & Checklist ➔A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
📍 City of Hope Medical Center — Pasadena, California
View Study & Checklist ➔A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
📍 Local Institution - 109 — Scottsdale, Arizona
View Study & Checklist ➔A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
📍 GSK Investigational Site — Canton, Ohio
View Study & Checklist ➔A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
📍 Colorado Blood Cancer Institute ( Site 7000) — Denver, Colorado
View Study & Checklist ➔Family Study of Lymphoproliferative Disorders
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔Epcoritamab-CAR T Cells for Large B-cell Lymphomas
📍 Abramson Cancer Center at the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
📍 City of Hope — Duarte, California
View Study & Checklist ➔TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
📍 University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
📍 Stanford University School of Medicine — Stanford, California
View Study & Checklist ➔